Literature DB >> 16893591

Malignant pleural effusion, current and evolving approaches for its diagnosis and management.

Siyamek Neragi-Miandoab1.   

Abstract

Malignant pleural effusion is a common and debilitating complication of advanced malignant diseases. This problem seems to affect particularly those with lung and breast cancer, contributing to the poor quality of life. Approximately half of all patients with metastatic cancer develop a malignant pleural effusion at some point, which is likely to cause significant symptoms such as dyspnea and cough. Evacuation of the pleural fluid and prevention of its re-accumulation are the main goals of management. Optimal treatment is controversial and there is no universally standard approach. Intervention options range from observation in the case of asymptomatic effusions through simple thoracentesis to more invasive methods such as chemical and mechanical pleurodesis, pleur-X catheter drainage, pleuroperitoneal shunting, and pleurectomy. The best results are reported with thoracoscopy and talc insufflation, with an acceptable morbidity. Development of novel methods to control malignant pleural effusion should be a high priority in palliative care of cancer patients. This article reviews the current, as well as, novel approaches that show some promise for the future. The aim is to identify the proper approach for each individual patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893591     DOI: 10.1016/j.lungcan.2006.04.016

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  31 in total

1.  Malignant pleural effusion: further translational research is crucial.

Authors:  Yasuhiko Nishioka
Journal:  Transl Lung Cancer Res       Date:  2012-09

2.  Clinical-therapeutic management of thoracoscopy in pleural effusion: a groundbreaking technique in the twenty-first century.

Authors:  José Marcelo Galbis; Manuel Mata; Ricardo Guijarro; Rafael Esturi; Salvador Figueroa; Antonio Arnau
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

3.  Sodium hydroxide as a sclerosing agent in patients with neoplastic pleural effusion non-candidates for VATS: results of a minimally invasive protocol.

Authors:  Micaela Raices; Matías E Czerwonko; Agustin Dietrich; Alejandro Da Lozzo; Enrique Beveraggi; David Smith
Journal:  Updates Surg       Date:  2017-08-31

4.  Pleurodesis with povidone-iodine, as an effective procedure in management of patients with malignant pleural effusion.

Authors:  Gholamali Godazandeh; Nasim Haji Qasemi; Mohammad Saghafi; Meisam Mortazian; Pouya Tayebi
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

5.  Caring for a patient with malignant pleural effusion.

Authors:  Jeanne Held-Warmkessel; Linda Schiech
Journal:  Nursing       Date:  2008-11

6.  Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis.

Authors:  Aaron M Olden; Robert Holloway
Journal:  J Palliat Med       Date:  2010-01       Impact factor: 2.947

7.  Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.

Authors:  R Kremer; L A Best; D Savulescu; M Gavish; R M Nagler
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

8.  Reactive oxygen metabolites can be used to differentiate malignant and non-malignant pleural efffusions.

Authors:  Ufuk Cobanoglu; Fuat Sayir; Duygu Mergan
Journal:  Ann Thorac Med       Date:  2010-07       Impact factor: 2.219

9.  WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions.

Authors:  Tsung-Ming Yang; Shaw-Wei Leu; Jhy-Ming Li; Ming-Szu Hung; Chu-Huan Lin; Yu-Ching Lin; Tung-Jung Huang; Ying-Huang Tsai; Cheng-Ta Yang
Journal:  J Cancer Res Clin Oncol       Date:  2008-12-16       Impact factor: 4.553

10.  Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model.

Authors:  Ianko D Iankov; Pavlos Msaouel; Cory Allen; Mark J Federspiel; Peggy A Bulur; Allan B Dietz; Dennis Gastineau; Yasuhiro Ikeda; James N Ingle; Stephen J Russell; Evanthia Galanis
Journal:  Breast Cancer Res Treat       Date:  2009-11-06       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.